Skip to main content
 

Cameron, P., Coons, M.M., Klompe, S.E. et al. Harnessing type I CRISPR–Cas systems for genome engineering in human cells. Nat Biotechnol 37, 1471–1477 (2019) doi:10.1038/s41587-019-0310-0.

Donohoue, P.D., Barrangou, R., & May, A.P. (2017). Advances in Industrial Biotechnology Using CRISPR-Cas Systems. Trends in Biotechnology.

Cameron, P., Fuller, C.K., Donohoue, P.D., Jones, B.N., Thompson, M.S., Carter, M.M., Gradia, S., Vidal, B., Garner, E., Slorach, E.M., Lau, E., Banh, L.M., Lied, A.M., Edwards, L.S., Settle, A.H., Capurso, D., Llaca, V., Deschamps, S. Cigan, M., Young, J.K., May, A.P. (2017). Mapping the genomic landscape of CRISPR-Cas9 cleavage. Nature Methods, 14(6), 600–606.

van Overbeek, M., Capurso, D., Carter, M.M., Thompson, M.S., Frias, E., Russ, C., Reece-Hoyes, J.S., Nye, C., Gradia, S., Vidal, B., Zheng, J., Hoffman, G.R., Fuller, C.K., May, A.P. (2017). DNA Repair Profiling Reveals Nonrandom Outcomes at Cas9-Mediated Breaks. Molecular Cell, 63(4), 633–646.

Briner, A. E., Donohoue, P.D., Gomaa, A. A., Selle, K., Slorach, E.M., Nye, C.H., Haurwitz, R.E., Beisel, C.L., May, A.P., Barrangou, R. (2014). Guide RNA Functional Modules Direct Cas9 Activity and Orthogonality. Molecular Cell, 56(2), 333-9.